GGrantIndex
Sort

15,440 grants matching organoids

Role of Aryl Hydrocarbon Receptor in Microbiota-Colon Stem Cell Interactions

$415,336
Robert Stephen Chapkin · Texas A&M Agrilife Research · R01 · FY2017 · ES

Role of type 2 immune response in pancreatic cancer tumorigenesis

$415,258
Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA

Racial Disparities and Colorectal DNA Methylation- Driven Gene Expression

$415,257
Li Li · University Of Virginia · R21 · FY2023 · CA

Project 1: Targeting autophagy for the treatment of KRAS-mutant PDAC

$415,212
Channing J Der · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA

Mechanistic Links Between Changing Estrogen Profiles, Inflammation and the Increased Risk and Metastasis of Breast Cancer in Obese Women

$415,197
Joyce Marie Slingerland · Georgetown University · R01 · FY2023 · CA

Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics

$415,165
Richard M Weinshilboum · Mayo Clinic Rochester · R01 · FY2024 · AA

Hes1-loss promotes dysregulation of epithelial homeostasis and inflammation in a serrated adenocarcinoma model

$415,163
Lan Zhou · Case Western Reserve University · R01 · FY2021 · CA

Hes1-loss promotes dysregulation of epithelial homeostasis and inflammation in a serrated adenocarcinoma model

$415,163
Lan Zhou · Case Western Reserve University · R01 · FY2020 · CA

Integration of systems and synthetic biology to advance development of human tissues ex vivo

$415,024
Mo Reza Ebrahimkhani · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · EB

BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma

$414,944
David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA

Adrenomedullin Signaling at the Maternal-Fetal Interface

$414,865
Kathleen M Caron · Univ Of North Carolina Chapel Hill · R01 · FY2024 · HD

The role of intestinal gp130 in alcohol-associated liver disease

$414,750
Ana Cristina Llorente Izquierdo · University Of California, San Diego · R21 · FY2023 · AA

Modeling axon growth and pathfinding of human retinal ganglion cells during development and disease

$414,711
Wei Liu · Albert Einstein College Of Medicine · R01 · FY2025 · EY

A novel, transferable sialylation-mediated mechanism of chemoradioresistance in GI cancer

$414,655
Karin Marie Hardiman · University Of Alabama At Birmingham · R01 · FY2022 · CA

Leveraging Tumor Suppressor Inactivation for Osteosarcoma Therapy

$414,585
Bang H Hoang · Albert Einstein College Of Medicine · R01 · FY2023 · CA

Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis

$414,491
Joshua John Breunig · Cedars-Sinai Medical Center · R33 · FY2024 · CA

Creating an improved oncolytic virus through directed evolution and virus-driven expression of a cancer-targeting peptid

$414,482
James D Weger · Virginia Polytechnic Inst And St Univ · R21 · FY2025 · AI

A New Molecular Mechanism to Bioengineering a Liver

$414,439
Eric Lagasse · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK

Translational Analysis Core

$414,283
Mary Kay Washington · Vanderbilt University Medical Center · P30 · FY2025 · DK

Translational Analysis Core

$414,283
Mary Kay Washington · Vanderbilt University Medical Center · P30 · FY2023 · DK

Translational Analysis Core

$414,283
Mary Kay Washington · Vanderbilt University Medical Center · P30 · FY2024 · DK

Translational Analysis Core

$414,283
Mary Kay Washington · Vanderbilt University Medical Center · P30 · FY2022 · DK

Polycystic Kidney Disease In Vitro Center (PKD-InVent)

$414,267
Benjamin Solomon Freedman · University Of Washington · U54 · FY2025 · DK

The Radium-223 Combination Therapy Space; Improving Response and Clarifying Toxicities

$414,138
Daniel Lyndon Jaffe Thorek · Washington University · R01 · FY2024 · CA

Elucidating Novel APE1 Redox-Dependent Functions in Esophageal Adenocarcinoma

$414,011
Wael El-Rifai · University Of Miami School Of Medicine · P01 · FY2025 · CA